Dana-Farber $15M FCA settlement (December 2025) — most recent precedent

In December 2025, the Dana-Farber Cancer Institute settled an FCA case for $15 million on six NIH grants under the implied-certification theory (S-0066). It is the most recent precedent in the sequence of research-related FCA settlements against major U.S. institutions.

The case is a preview of what fraud-pattern cases settled under the maturing mandate regime look like, not a forecast of architectural cases at scale. But its structure — implied-certification theory applied to NIH grant submissions where compliance representations could not be independently verified — establishes the template the architectural extension would build on.

The 5-year cadence of major settlements (2017 Harvard-Anversa, 2019 Duke, 2025 Dana-Farber) represents a stable enforcement environment rather than a one-off. Each settlement establishes the precedent stack at a rough institutional-event magnitude. The compliance regime now maturing (C-0025) is what determines whether enforcement scales to the architectural fact pattern in subsequent cycles.

For M-0003 Term D, this is the most recent anchor — December 2025 sets the immediate baseline against which 2026-2027 institutional decisions about architectural deployment are made.